Case study: Market Overview of Opioids | Blueocean MI

© Copyright

An Illustrative case study

Market Overview of Opioids

© 2014 blueocean market intelligence

Project Objective & Methodology

2


Content

An Overview: International Conventions and Guidelines

3


Regulatory Heat Map (Focus Regions)

Country Summary

4

Country rank ordering

framework

Simple: Pathways are rational/High degree of overall acceptance/Low operational barrier

Complex: Pathways are not well defined/Low degree of overall acceptance/High operational barrier

*Based on quantitative matrix


Content

5


Methodology – Current and Future Market Sizing

6


Consumption Patterns - Country 1

7

Historical Data Analysis - 2010


Methodology – Current and Future Market Sizing

8




9

Historical Data Analysis - 2012

Forecasted Data Analysis - 2023


Focus Geography Snapshot in 2010 & 2012

Focus Geography Snapshot Estimated in 2023

10

Reported and Estimated Opioid Revenues and Volumes in each Geography

Forecasted Opioid Revenues and Volumes in each Geography


Content

Country Prioritization for Focus Geographies

11


Regulatory Intelligence (1/2)

Regulatory Intelligence (2/2)

12

Opioid are recognized for pain management in Country 1

Narcotic guidelines are well established in Country 1 being a member of Single Convention


Hurdles around Opioid usage in Pain Management

Activities to Rationalize the Opioid Usage

13

Average clinical decision making standard for pain management is observed in Country 1


Content

14


Methodology for Screening of Potential Partners

15


Prioritization of Potential Companies for Partnership

Top Brands - Global

16


Key Brands (Country – C1)

17


Content

Preferred Category and Brands of Opioids

18

Convergence in usage of Morphine, Fentanyl and Oxycodone for pain management is seen between INCB and PMR data


Availability and Accessibility of OBA

Conditions for Opioid Prescription

19

Convergence in the type of hurdles in OBA usage is seen between secondary research and PMR data

OBA are prescribed for both malignant and non-malignant pain types in Country 1


New Developments in Narcotics Drugs Space

20


Content

Abbreviations / Acronyms

21

Proprietary and Confidential

For further information, please contact: Suchitra Eswaran Vice President – Life Sciences [email protected]

Seattle |Chicago | Cincinnati | Bangalore | Dubai www.blueoceanmi.com

Case study: Market Overview of Opioids | Blueocean MI

Documents

Transcript of Case study: Market Overview of Opioids | Blueocean MI